Altria raises quarterly dividend to $1.11 per share

scanx
Reviewed by
Naman SScanX News Team
Key Highlights
  • Altria Group raises quarterly dividend to $1.11 from $1.06
  • The increase marks the 61st dividend hike in 57 years
  • Annualized rate stands at $4.44 per share
  • Yield is 6.4% based on August 26 closing price of $69.12
  • Payment date is October 9, 2026 for record holders as of September 15
powered bylight_fuzz_icon
49403097

*this image is generated using AI for illustrative purposes only.

Altria Group, Inc. (NYSE: MO) announced a 4.7% increase in its regular quarterly dividend to $1.11 per share. This marks the company’s 61st dividend increase in the past 57 years.

The payout reflects Altria’s progressive dividend goal, which targets mid-single-digit annual growth through 2028. The new quarterly rate replaces the previous $1.06 per share.

Dividend Details

The updated dividend schedule is as follows:

Metric Value
New Quarterly Dividend $1.11 per share
Previous Quarterly Dividend $1.06 per share
Annualized Rate $4.44 per share
Record Date September 15, 2026
Payment Date October 9, 2026

Yield Context

Based on a closing stock price of $69.12 on August 26, 2026, the new annualized dividend rate implies a yield of 6.4%. This calculation provides context for income-focused investors evaluating the current payout against market valuation.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

How might Altria's commitment to mid-single-digit dividend growth through 2028 impact its capital allocation strategy for emerging product lines like vaping or nicotine pouches?

Given the 6.4% yield, how does Altria's dividend sustainability compare to other high-yield tobacco and consumer staples peers in a rising interest rate environment?

What are the potential risks to maintaining this dividend growth trajectory if regulatory pressures on traditional combustible cigarettes intensify over the next three years?

like15
dislike

Altria, Philip Morris sign manufacturing pact for operational efficiency

scanx
Reviewed by
Anirudha BScanX News Team
Key Highlights
  • Altria and Philip Morris signed a contract manufacturing pact for traditional tobacco products
  • Initial shipments under the agreement are expected to begin in early 2027
  • The deal supports Altria's 2028 Enterprise Goals without impacting 2026 financial results
  • Both companies will remain independent, retaining separate commercial and regulatory responsibilities
  • Altria stock rose 3.87% following the announcement
powered bylight_fuzz_icon
49115361

*this image is generated using AI for illustrative purposes only.

Altria Group Inc (NYSE: MO) and Philip Morris International Inc (NYSE: PM) have entered into a contract manufacturing arrangement to enhance the operational efficiency of Philip Morris USA Inc’s traditional tobacco product operations.

The agreement leverages the respective capabilities of both entities in combustible cigarette manufacturing. Initial shipments under the arrangement are expected to begin in early 2027, subject to operational readiness and applicable regulatory requirements. Altria stated that it does not expect the deal to have a material impact on its 2026 financial results.

Strategic Context

The pact aims to support Altria’s 2028 Enterprise Goals by generating economic benefits and strengthening operating capabilities. These enhanced capabilities are transferable to Altria’s international nicotine initiatives. The company noted that the agreement should improve the efficiency of Philip Morris USA’s traditional tobacco operations while supporting broader strategic investments.

Altria emphasized that both entities will continue to operate independently. Each party retains full responsibility for its own commercialization, distribution, and regulatory activities. PMI confirmed it has not commercialized combustible cigarettes in the U.S. and has no plans to do so, a position unchanged by this manufacturing agreement.

Portfolio Overview

Altria’s wholly owned subsidiaries include Philip Morris USA Inc, the most profitable U.S. cigarette manufacturer, and John Middleton Co, a leading U.S. cigar manufacturer. Its smoke-free portfolio includes U.S. Smokeless Tobacco Company LLC, Helix Innovations LLC, and NJOY LLC.

Additionally, Altria holds a majority stake in Horizon Innovations LLC for heated tobacco stick marketing in the U.S. The company also maintains equity investments in Anheuser-Busch InBev SA/NV and Cronos Group Inc.

Market Reaction

Altria shares rose 3.87% to $68.65, while Philip Morris shares gained 2.60% to $193.12 on Monday. At $67.84 earlier in the session, Altria traded 3.4% above its 200-day simple moving average of $65.89, keeping the longer-term trend intact. However, shares remained 2.9% below the 50-day SMA of $70.16, indicating the intermediate trend has yet to fully recover. The stock’s relative strength index stood at 50.59, signaling neutral momentum.

Key resistance sits near $74, while support is around $63.50.

Analyst Outlook

Altria stock trades at a price-to-earnings multiple of 13.9 times. It carries a Hold consensus rating with an average price target of $70.

Barclays maintained an Underweight rating and lowered its price target to $58 on Aug. 11. Barclays previously raised its target to $64 on May 15 while maintaining an Underweight rating. UBS maintained a Buy rating and raised its target to $79 on July 7.

ETF Exposure

Significant inflows or outflows from funds with large Altria holdings can result in corresponding purchases or sales of shares. Key ETFs include:

ETF Name Ticker Weight
GQG US Equity ETF GQGU 5.64%
ETC 6 Meridian Hedged Equity Index Option ETF SIXH 5.43%
WisdomTree US High Dividend Fund DHS 4.95%
Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

How might the transfer of manufacturing capabilities to Altria's international nicotine initiatives accelerate its global expansion timeline?

What regulatory hurdles could delay the initial shipments scheduled for early 2027, and how might this impact Altria's 2028 Enterprise Goals?

Will this contract manufacturing arrangement allow Philip Morris International to reallocate capital more aggressively toward smoke-free products in other markets?

like15
dislike

More News on Altria Group